Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Pleural Disease
Is there any utility in using lytics for loculated malignant pleural effusion?
Answer from: at Community Practice
Yes. We frequently use tPA for loculated MPE or non-draining TPC clinically. There are many small studies on the subject with mixed results.
Sign In
or
Register
to read more
18057
Related Questions
What duration of antibiotic therapy do you use for a loculated parapneumonic effusion that does not meet criteria for empyema?
Do you consider indwelling pleural catheters in patients with refractory transudative pleural effusions?
Do you routinely discontinue atypical coverage in community-acquired pneumonia when PCR testing (i.e., respiratory pathogen panel) is negative for atypical organisms?
What are some immunosuppression regimens to consider in a patient with refractory cardiac sarcoidosis?
What is the role of mechanical circulatory support in mixed cardiogenic vasodilatory shock?
When, if ever, would you consider methotrexate over prednisone for first line therapy in patients with pulmonary sarcoidosis?
How do you weigh the risk of urinary catheter or fecal management system placement with that of soiling sacral wounds?
Do you prescribe lower dose ICS for asthma to mitigate the risk of pneumonia in patients with a history of respiratory infections or compromised immune systems?
When do you consider diaphragmatic pacing in patients with diaphragmatic paresis?
How do you mitigate risk when performing bronchoscopy in hypoxic patients requiring high levels of supplemental oxygen?